Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ana Lorenzo-Vizcaya, Serena Fasano & David A Isenberg. (2020) Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?. ImmunoTargets and Therapy 9, pages 105-110.
Read now
Read now
Sebastian Torke & Martin S. Weber. (2020) Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis. Expert Opinion on Investigational Drugs 29:10, pages 1143-1150.
Read now
Read now
Mohammad Hojjat-Farsangi. (2016) Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances. Journal of Drug Targeting 24:3, pages 192-211.
Read now
Read now
Linda M Hartkamp, Timothy RDJ Radstake & Kris A Reedquist. (2015) Bruton’s tyrosine kinase in chronic inflammation: from pathophysiology to therapy. International Journal of Interferon, Cytokine and Mediator Research 7, pages 27-34.
Read now
Read now
Rajshekhar Chakraborty, Stephen A Ansell, Prashant Kapoor & Morie A Gertz. (2015) Phase II clinical trials for Waldenstrom’s macroglobulinemia. Expert Opinion on Orphan Drugs 3:5, pages 537-547.
Read now
Read now
Peter Norman. (2014) Inducible tyrosine kinase inhibitors: a review of the patent literature (2010 – 2013). Expert Opinion on Therapeutic Patents 24:9, pages 979-991.
Read now
Read now
Nicole J. Horwood. (2013) Immune cells and bone: coupling goes both ways. Immunological Investigations 42:7, pages 532-543.
Read now
Read now
Articles from other publishers (47)
Rwan Elsanhoury, Abdulaziz Alasmari, Prashanth Parupathi, Mouhannad Jumaa, Suliman Al-Fayoumi, Avinash Kumar, Raed Khashan, Sami Nazzal & Ahmed Abu Fayyad. (2023) AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics. International Journal of Pharmaceutics 645, pages 123384.
Crossref
Crossref
Senthilnathan Palaniyandi, Ethan Strattan, Reena Kumari, Miranda Mysinger, Natalya Hakim, Melissa V. Kesler, Mutiah Apatira, Fabiola Bittencourt, Longcheng Wang, Zhaozhong Jia, Tarikere L. Gururaja, Ronald J. Hill & Gerhard C. Hildebrandt. (2023) Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease. Bone Marrow Transplantation 58:8, pages 924-935.
Crossref
Crossref
J Kanter, S M Gordon, S Mani, A Sokalska, J Y Park, S Senapati, D D Huh & M Mainigi. (2023) Hormonal stimulation reduces numbers and impairs function of human uterine natural killer cells during implantation. Human Reproduction 38:6, pages 1047-1059.
Crossref
Crossref
Qinqin Meng, Mei Bai, Meiliang Guo, Zhengxiao Li, Wanwen Liu, Xiaojing Fan, Rui Sun, Xinrong Yang, Dingfen Yuan, Yuling Shi & Hui Deng. (2023) Inhibition of Serum- and Glucocorticoid-Regulated Protein Kinase-1 Aggravates Imiquimod-Induced Psoriatic Dermatitis and Enhances Proinflammatory Cytokine Expression through the NF-kB Pathway. Journal of Investigative Dermatology 143:6, pages 954-964.
Crossref
Crossref
Kamira Maharaj, Angimar Uriepero, Eva Sahakian & Javier Pinilla-Ibarz. (2022) Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. Frontiers in Immunology 13.
Crossref
Crossref
Xiaoming Yang, Alex C. Rutkovsky, Juhua Zhou, Yin Zhong, Julian Reese, Timothy Schnell, Helmut Albrecht, William B. Owens, Prakash S. Nagarkatti & Mitzi Nagarkatti. (2022) Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients. The Journal of Immunology 208:8, pages 1968-1977.
Crossref
Crossref
Vikrant Rai & Devendra K. Agrawal. (2022) Transcriptomic Analysis Identifies Differentially Expressed Genes Associated with Vascular Cuffing and Chronic Inflammation Mediating Early Thrombosis in Arteriovenous Fistula. Biomedicines 10:2, pages 433.
Crossref
Crossref
Sai-Fung Yeung, Yuan Zhou, Wenjun Zou, Wing-Lim Chan & Yick Pang Ching. (2022) TEC kinase stabilizes PLK4 to promote liver cancer metastasis. Cancer Letters 524, pages 70-81.
Crossref
Crossref
Lydia Ntari, Christoforos Nikolaou, Ksanthi Kranidioti, Dimitra Papadopoulou, Eleni Christodoulou-Vafeiadou, Panagiotis Chouvardas, Florian Meier, Christina Geka, Maria C. Denis, Niki Karagianni & George Kollias. (2021) Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment. Journal of Translational Medicine 19:1.
Crossref
Crossref
Zehra Kevser Timur, Orhan Kerim Inci, Secil Akyildiz Demir & Volkan Seyrantepe. (2021) Sialidase neu4 deficiency is associated with neuroinflammation in mice. Glycoconjugate Journal 38:6, pages 649-667.
Crossref
Crossref
Yixiao Zeng, Kaiqiong Zhao, Kathleen Oros Klein, Xiaojian Shao, Marvin J. Fritzler, Marie Hudson, Inés Colmegna, Tomi Pastinen, Sasha Bernatsky & Celia M. T. Greenwood. (2021) Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals. Genes 12:9, pages 1349.
Crossref
Crossref
Mark C. Genovese, Alberto Spindler, Akira Sagawa, Won Park, Anna Dudek, Alan Kivitz, Jeannie Chao, Lai Shan Melanie Chan, Jennifer Witcher, William Barchuk & Ajay Nirula. (2021) Safety and Efficacy of Poseltinib, Bruton’s Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study. The Journal of Rheumatology 48:7, pages 969-976.
Crossref
Crossref
A K M Nawshad Hossian, Fatema Tuz Zahra, Sagun Poudel, Camille F. Abshire, Paula Polk, Jone Garai, Jovanny Zabaleta, Constantinos M. Mikelis & George Mattheolabakis. (2021) Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance. Scientific Reports 11:1.
Crossref
Crossref
Michael Forster, Xiaojun Julia Liang, Martin Schröder, Stefan Gerstenecker, Apirat Chaikuad, Stefan Knapp, Stefan Laufer & Matthias Gehringer. (2020) Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK. International Journal of Molecular Sciences 21:23, pages 9269.
Crossref
Crossref
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al-Harbi, Khalid E. Ibrahim, Faleh Alqahtani, Homood M. As Sobeai & Moureq R. Alotaibi. (2020) Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Biochimie 179, pages 146-156.
Crossref
Crossref
Hyewon Cho, Eun Lee, Hye Ah Kwon, Lee Seul, Hui-Jeon Jeon, Ji Hoon Yu, Jae-Ha Ryu & Raok Jeon. (2020) Discovery of Tricyclic Pyranochromenone as Novel Bruton’s Tyrosine Kinase Inhibitors with In Vivo Antirheumatic Activity. International Journal of Molecular Sciences 21:21, pages 7919.
Crossref
Crossref
João D. Seixas, Bárbara B. Sousa, Marta C. Marques, Ana Guerreiro, Rui Traquete, Tiago Rodrigues, Inês S. Albuquerque, Marcos F. Q. Sousa, Ana R. Lemos, Pedro M. F. Sousa, Tiago M. Bandeiras, Di Wu, Shelby K. Doyle, Carol V. Robinson, Angela N. Koehler, Francisco Corzana, Pedro M. Matias & Gonçalo J. L. Bernardes. (2020) Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors. RSC Chemical Biology 1:4, pages 251-262.
Crossref
Crossref
Kai Li, Wen-ting Pan, Yan-bin Ma, Xiao-long Xu, Yang Gao, Yan-qi He, Lei Wei & Jing-wei Zhang. (2019) BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer. Breast Cancer 27:3, pages 363-371.
Crossref
Crossref
Julien Blaess, Julia Walther, Arthur Petitdemange, Jacques-Eric Gottenberg, Jean Sibilia, Laurent Arnaud & Renaud Felten. (2020) Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2095997.
Crossref
Crossref
Kata P. Szilveszter, Tamás Németh & Attila Mócsai. (2019) Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases. Frontiers in Immunology 10.
Crossref
Crossref
Yiteng Meng, Shuo Sha, Jing Yang & Hongbo Ren. (2019) Effects of Tec Tyrosine Kinase Inhibition on the Inflammatory Response of Severe Acute Pancreatitis-Associated Acute Lung Injury in Mice. Digestive Diseases and Sciences 64:8, pages 2167-2176.
Crossref
Crossref
Lina Wang, Hong Zhang, Ming Dong, Meina Zuo, Shuo Liu, Ying Lu & Weidong Niu. (2019)
Role of the Btk-PLC
γ
2 Signaling Pathway in the Bone Destruction of Apical Periodontitis
. Mediators of Inflammation 2019, pages 1-10.
Crossref
Crossref
Ming Dong, Haiwei Jin, Meina Zuo, Hua Bai, Lina Wang, Chun Shi & Weidong Niu. (2019) The potential effect of Bruton’s tyrosine kinase in refractory periapical periodontitis. Biomedicine & Pharmacotherapy 112, pages 108710.
Crossref
Crossref
Anne R Bresnick & Jonathan M Backer. (2019) PI3Kβ—A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling. Endocrinology 160:3, pages 536-555.
Crossref
Crossref
Wataru Kawahata, Tokiko Asami, Takao Kiyoi, Takayuki Irie, Haruka Taniguchi, Yuko Asamitsu, Tomoko Inoue, Takahiro Miyake & Masaaki Sawa. (2018) Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton’s Tyrosine Kinase Inhibitors for Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry 61:19, pages 8917-8933.
Crossref
Crossref
Sujal Ghosh, Ingo Drexler, Sanil Bhatia, Heiko Adler, Andrew R. Gennery & Arndt Borkhardt. (2018) Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?. Frontiers in Immunology 9.
Crossref
Crossref
Theresa H. Page, Anna M. Urbaniak, Ana I. Espirito Santo, Lynett Danks, Timothy Smallie, Lynn M. Williams & Nicole J. Horwood. (2018) Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment. Biochemical and Biophysical Research Communications 499:2, pages 260-266.
Crossref
Crossref
Mario E. Cruz-Muñoz & Ezequiel M. Fuentes-Pananá. (2018) Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System. Frontiers in Microbiology 8.
Crossref
Crossref
Wataru Kawahata, Tokiko Asami, Takayuki Irie & Masaaki Sawa. (2018) Design and synthesis of novel pyrimidine analogs as highly selective, non-covalent BTK inhibitors. Bioorganic & Medicinal Chemistry Letters 28:2, pages 145-151.
Crossref
Crossref
Fei Wang, Wei Zhang, Chao Wang, Xu Fang, Hao Cheng, Sheng Liu & Xu-Lin Chen. (2017) Inhibitor of Tec kinase, LFM-A13, decreases pro-inflammatory mediators production in LPS-stimulated RAW264.7 macrophages via NF-κB pathway. Oncotarget 8:21, pages 34099-34110.
Crossref
Crossref
Philip Gotwals, Scott Cameron, Daniela Cipolletta, Viviana Cremasco, Adam Crystal, Becker Hewes, Britta Mueller, Sonia Quaratino, Catherine Sabatos-Peyton, Lilli Petruzzelli, Jeffrey A. Engelman & Glenn Dranoff. (2017) Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nature Reviews Cancer 17:5, pages 286-301.
Crossref
Crossref
Evan C Lien, Christian C Dibble & Alex Toker. (2017) PI3K signaling in cancer: beyond AKT. Current Opinion in Cell Biology 45, pages 62-71.
Crossref
Crossref
Jean-Baptiste Telliez, Martin E. Dowty, Lu Wang, Jason Jussif, Tsung Lin, Li Li, Erick Moy, Paul Balbo, Wei Li, Yajuan Zhao, Kimberly Crouse, Caitlyn Dickinson, Peter Symanowicz, Martin Hegen, Mary Ellen Banker, Fabien Vincent, Ray Unwalla, Sidney Liang, Adam M. Gilbert, Matthew F. Brown, Matthew Hayward, Justin Montgomery, Xin Yang, Jonathan Bauman, John I. Trujillo, Agustin Casimiro-Garcia, Felix F. Vajdos, Louis Leung, Kieran F. Geoghegan, Amira Quazi, Dejun Xuan, Lyn Jones, Erik Hett, Katherine Wright, James D. Clark & Atli Thorarensen. (2016) Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition. ACS Chemical Biology 11:12, pages 3442-3451.
Crossref
Crossref
Ewa Marcinkowska & Elżbieta Gocek. 2016. Resistance to Tyrosine Kinase Inhibitors. Resistance to Tyrosine Kinase Inhibitors
1
25
.
Chun-Yu Chen, Yann-Lii Leu, Yu Fang, Chwan-Fwu Lin, Liang-Mou Kuo, Wei-Che Sung, Yung-Fong Tsai, Pei-Jen Chung, Ming-Chung Lee, Yu-Ting Kuo, Hsuan-Wu Yang & Tsong-Long Hwang. (2015) Anti-inflammatory effects of Perilla frutescens in activated human neutrophils through two independent pathways: Src family kinases and Calcium. Scientific Reports 5:1.
Crossref
Crossref
Linda M Hartkamp, Jay S Fine, Inge E van Es, Man Wai Tang, Michael Smith, John Woods, Satwant Narula, Julie DeMartino, Paul P Tak & Kris A Reedquist. (2015) Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants. Annals of the Rheumatic Diseases 74:8, pages 1603-1611.
Crossref
Crossref
Tokiko Asami, Wataru Kawahata & Masaaki Sawa. (2015) TR-FRET binding assay targeting unactivated form of Bruton’s tyrosine kinase. Bioorganic & Medicinal Chemistry Letters 25:10, pages 2033-2036.
Crossref
Crossref
Wataru Kawahata, Tokiko Asami, Ikuo Fujii & Masaaki Sawa. (2015) ‘Turn On/Off’ fluorescence probe for the screening of unactivated Bruton’s tyrosine kinase. Bioorganic & Medicinal Chemistry Letters 25:10, pages 2141-2145.
Crossref
Crossref
Yiming Zhong, Shuai Dong, Ethan Strattan, Li Ren, Jonathan P. Butchar, Kelsey Thornton, Anjali Mishra, Pierluigi Porcu, J. Michael Bradshaw, Angelina Bisconte, Timothy D. Owens, Erik Verner, Ken A. Brameld, Jens Oliver Funk, Ronald J. Hill, Amy J. Johnson & Jason A. Dubovsky. (2015) Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694. Journal of Biological Chemistry 290:10, pages 5960-5978.
Crossref
Crossref
Sandra Marmiroli, Doriano Fabbro, Yoshihiko Miyata, Mariaelena Pierobon & Maria Ruzzene. (2015) Phosphorylation, Signaling, and Cancer: Targets and Targeting. BioMed Research International 2015, pages 1-3.
Crossref
Crossref
Florian Zwolanek, Michael Riedelberger, Valentina Stolz, Sabrina Jenull, Fabian Istel, Afitap Derya Köprülü, Wilfried Ellmeier & Karl Kuchler. (2014) The Non-receptor Tyrosine Kinase Tec Controls Assembly and Activity of the Noncanonical Caspase-8 Inflammasome. PLoS Pathogens 10:12, pages e1004525.
Crossref
Crossref
Sujal Ghosh, Kirsten Bienemann, Kaan Boztug & Arndt Borkhardt. (2014) Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects. Journal of Clinical Immunology 34:8, pages 892-899.
Crossref
Crossref
Vassilios Lougaris, Manuela Baronio, Massimiliano Vitali, Giacomo Tampella, Marco Cattalini, Laura Tassone, Annarosa Soresina, Raffaele Badolato & Alessandro Plebani. (2014) Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. Journal of Allergy and Clinical Immunology 133:6, pages 1644-1650.e4.
Crossref
Crossref
Sarah E. Wythe, Vicky Nicolaidou & Nicole J. Horwood. (2013) Cells of the Immune System Orchestrate Changes in Bone Cell Function. Calcified Tissue International 94:1, pages 98-111.
Crossref
Crossref
Raji E. JosephIivari KleinoThomas E. WalesQian XieD. Bruce FultonJohn R. EngenLeslie J. BergAmy H. Andreotti. (2013) Activation Loop Dynamics Determine the Different Catalytic Efficiencies of B Cell– and T Cell–Specific Tec Kinases. Science Signaling 6:290.
Crossref
Crossref
John J. O'Shea, Arian Laurence & Iain B. McInnes. (2013) Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nature Reviews Rheumatology 9:3, pages 173-182.
Crossref
Crossref
Natalia V Giltiay, Craig P Chappell & Edward A Clark. (2012) B-cell selection and the development of autoantibodies. Arthritis Research & Therapy 14:Suppl 4, pages S1.
Crossref
Crossref